Effects of Spironolactone in an Experimental Model of Chronic Cyclosporine Nephrotoxicity

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 273-278

  Macunluoglu, B ^a   Arikan, H ^a   Atakan, A ^a   Tuglular, S ^a   Ulfer, G ^a   Cakalagaoglu, F ^a   Ozener, C ^a   Akoglu, E ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; PLATELET DERIVED GROWTH FACTOR B; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CREATININE; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; INJECTIONS, INTRAPERITONEAL; KIDNEY; MALE; POTASSIUM; PROTEINURIA; RATS; RATS, WISTAR; SPIRONOLACTONE;

EID: 38749151294     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.11.025     Document Type: Article

References (37)

1. Kahan B.D. Cyclosporine. N Engl J Med 321 (1738) 1725
2. Bennett W.M., Demattos A., Meyer M.M., et al. Chronic cyclosporine nephropathy: the Achilles heel of immunosuppressive therapy. Kidney Int 50 (1996) 1089
3. Zhong Z., Arteel G.E., Connor H.D., et al. Cyclosporine A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 275 (1998) F595
4. Thomas S.E., Andoh T.F., Pichler R.H., et al. Accelerated apoptosis characterizes CsA associated interstitial fibrosis. Kidney Int 53 (1998) 897
5. Viera Jr. J.M., Noronha I.L., Malheiros D.M., et al. CsA induced interstitial fibrosis and arteriolar TGF beta expression. Transplantation 68 (1999) 1746
6. Nakamura T., Miller D., Ruoslahti E., et al. Production of extracellular matrix by glomerular cells is regulated by TGF beta 1. Kidney Int 41 (1990) 1213
7. Ignotz R.A., and Massague J. TGF beta stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 261 (1986) 4337
8. Floege J., and Johnson R.J. Multiple roles of platelet derived growth factor in renal disease. Miner Electrolyte Metab 21 (1995) 271
9. Shihab F.S., Andoh T.F., Tanner A.M., et al. Role of TGF beta in experimental chronic CsA nephropathy. Kidney Int 49 (1996) 1141
10. Shehata M., Cope G.H., Johnson T.S., et al. CsA enhances the expression of TGF beta in the juxtaglomerular cells of the rat kidney. Kidney Int 48 (1995) 1487
11. Thomas S.E., Andoh T.F., Pichler R.H., et al. Accelerated apoptosis characterizes CsA associated interstitial fibrosis. Kidney Int 53 (1998) 897
12. Schultz P.J., DiCorleta P.E., Silver B.J., et al. Mesangial cells express PDGF-B mRNA and proliferate in response to PDGF-B. Am J Physiol 255 (1988) F674
13. Throckmorton D.C., Brogden A., Min B., et al. PDGF-B and TGF beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48 (1995) 111
14. Kon V., Sugura M., and Inagami T. TEAL: role of endothelin in CsA induced glomerular dysfunction. Kidney Int 37 (1990) 1487
15. Thomson A.W., McAuley F.T., Whitting P.H., et al. ACE inhibition reduces CsA nephrotoxicty in the rat. Transplant Proc 19 (1987) 1242
16. Ichiwaka I., and Harris R.C. Angiotensin actions in the kidney. Kidney Int 40 (1991) 583
17. Wof G., and Neilson E.G. Angiotensin II as a renal growth factor. J Am Soc Nephrol 3 (1993) 1531
18. Kagami S., Border W.A., Miller D.E., et al. Angiotensin II stimulates ECM protein synthesis through induction of TGF beta expression in rat glomerular mesangial cells. J Clin Invest 93 (1994) 2431
19. Burdmann E.A., Andoh T.F., Nast C.C., et al. Prevention of experimental CsA induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269 (1995) 491
20. Greene E.L., Kren S., and Hostetter T.H. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98 (1996) 1063
21. Rocha R., Chander P.N., Khanna K., et al. Mineralocorticoid blockade reduces vascular injury in stroke prone hypertensive rats. Hypertension 31 (1998) 451
22. Hostetter T.H., Rosenberg M.E., and Ibrahim H.N. Aldosterone in renal disease. Curr Opin Nephrol Hypertens 12 (2003) 159
23. Shihab F.S., Bennett W.M., Tanner A.M., et al. Angiotensin II blockade decreases TGF beta 1 and matrix proteins in CsA nephropathy. Kidney Int 52 (1997) 660
24. Myers B.D., Sibley R., Newton L., et al. The long term course of CsA associated chronic nephropathy. Kidney Int 33 (1988) 590
25. Bobadilla N.A., Tapia E., Franco M., et al. Role of NO in renal hemodynamic abnormalities of CsA nephrotoxicity. Kidney Int 46 (1994) 773
26. Bunchman T.E., and Brookshire C.A. CsA induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88 (1991) 310
27. Stahl R.A.K., Adler S., and Baker P.J. CsA inhibits PGE2 formation by rat mesangial cells in culture. Kidney Int 35 (1989) 1161
28. Kon V., Hunley T.E., and Fogo A. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 60 (1995) 89
29. Andoh T.F., Gardner M.P., and Bennett W.M. Protective effects of dietary L-arginine supplementation on chronic CsA nephrotoxicity. Transplantation 64 (1997) 1236
30. Kang D.H., Kim Y.G., and Andoh T.F. CsA mediated nephropathy: amelioration by VEGF. Am J Renal Physiol 262 (1992) 679
31. Schwedler S.B., Bobadilla N., Striker L.J., et al. Pentosan polysulfate treatment reduces CsA nephropathy in salt depleted rats. Transplantation 68 (1995) 89
32. Shihab F.S., Bennett W.M., and Tanner A. Angiotensin II blockade decreases TGF beta 1 and matrix proteins in CsA nephropathy. Kidney Int 52 (1997) 660
33. Juknevicius, et al. Continuous infusion of aldosterone in normal rats induced up regulation of TGF beta in the kidney. J Am Soc Nephrol 11 (2000) 622A
34. Rocha R., Chander P.N., Khana K., et al. Role of aldosterone in renal vascular injury in stroke prone hypertensive rats. Hypertension 33 (1999) 232
35. Greene E.L., Kren S., and Hostetter T.H. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98 (1996) 1063
36. Feria I., Pichardo I., Juarez P., et al. Therapeutic benefit of spironolactone in experimental chronic CsA nephrotoxicity. Kidney Int 63 (2003) 43
37. Floege J., Burns W.M., Alpers C.E., et al. Glomerular cell proliferation and PDGF-B expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41 (1992) 297